Healthcare -
Biotechnology - NASDAQ - US
$ 16.5
0.671 %
$ 3.9 B
Market Cap
61.11
P/E
ADMA - LONG-TERM DEBT
Long-term Debt ADMA - ADMA Biologics, Inc.
140 M
LAST VALUE
17.12%
2 YEAR CAGR
26.00%
5 YEAR CAGR
39.41%
10 YEAR CAGR